Over-the-Counter Pain Medication Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, Australia, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

Over-the-Counter Pain Medication Market size is projected to experience significant growth from 2019 to 2025.
 

Over-the-counter pain medications are directly available to consumer from the drug store without any prescription. The pain management medication can be easily available in various form such as oral, topical, etc.
 

Get more details on this report - Request Free Sample PDF
 

The demand for over-the-counter pain management drugs is growing rapidly. The growth is attributed to rising number of people suffering from chronic pain across the globe. Rise in number of accidents, sports injury and heavy-duty workloads will create high demand for these pain reliefs. Likewise, growing prevalence of fever, muscle aches, inflammation, headache, etc. will further stimulate the market growth. Escalating knowledge about drug fact labeling (DFL) amongst people & cost-effectiveness related with OTC drugs will help drive industrial development.
 

Various market players are developing combination drugs & attractive packaging style to make the product easy to use, especially in cases of tube creams and spray bottles. They are prominently aiming to produce more enhanced pain relievers with quick action. Moreover, easy availability & high effectiveness of OTC pain medications will positively impact the growth of market. However, rising awareness among users regarding adverse side effects on excessive usage of OTC pain relievers will hamper market growth.
 

Global over-the-counter pain medication market is categorized into drug type, route of administration, dosage form, distribution channel, and region. The drug type segment is further sectored into acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs). Amongst this segment acetaminophen has dominated the business over the analysis timeframe. They are most commonly utilized pain relievers in adults owing to their usage in relieving fever & muscle pain. The consumption of acetaminophen is boosting due to ease of access in form of tablets, capsules & liquid suspensions in multiple drug stores. In addition, owing to increasing cases of chronic disorders & pain management solutions coupled with its safety, the segment is showing an upward trend. 
 

Based on route of administration, the market is sectored into oral and topical. Oral route is the fastest growing segment & has dominated OTC pain medication market growth. The growth is mainly due to advantages experienced by consumers such as convenience, compatibility, safety & affordability. Moreover, pain killers in numerous forms such as tablets, capsules, liquids or chewable tablets can be consumed orally. Thereby, aforementioned factors increase the preference of users towards oral consumption, eventually leading to segmental expansion.
 

The dosage form segment is further bifurcated into tablet, capsules, creams, gels and sprays. Amongst them, creams are projected to show significant growth in forthcoming years. Ease in application, faster pain relief for muscle pains and cheap price are key factors contributing to the segmental progress. In addition, rise in players manufacturing pain relief creams coupled with surge in muscular pains will boom the segmental growth.
 

On the basis of distribution channel, the market is classified into hospital pharmacies, retail pharmacies, online pharmacies and others. Online pharmacies segment for over-the-counter pain medicines is predicted to grow at robust pace over the analysis period. Easy availability of medications, door-step delivery, user-friendliness, price comparison, discounts, etc. offered by web pharmacies will influence the overall segmental growth. In addition, rise in adoption of mobiles and digital payments methods will boom the segmental growth.
 

U.S. over-the-counter pain medication market will hold considerable revenue size over the estimation period. Escalating inclination towards OTC drugs for minor injuries coupled with increasing tendency of self-medication, will stimulate the growth in the U.S. Additionally, soaring healthcare expenditure, emergence of e-health, favorable regulatory scenario and presence of major players in the country will fuel industry growth.
 

India over-the-counter pain medication market is projected to grow at a momentous pace in the coming years. Mounting healthcare spending, unhealthy dietary habits, enlarging population and developing healthcare awareness will propel industry growth. Furthermore, presence of key market players, start-ups & rising number of online pharmacies in this region will spur demand for OTC pain medications.
 

Some of the major market players involved in the global over-the-counter pain medication market are Pfizer, Inc., Sanofi S.A., Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Bayer AG, among few other players. Strategic initiatives such as launch of novel tests for over-the-counter pain medication, acquisitions and expansion of testing facilities are being adopted by these firms to fortify their business growth. For instance, in April 2019, Granules India announced that it received U.S. FDA approval for acetaminophen 650 mg extended-release tablets, intended for temporary pain relief. The launch helped the firm to expand its OTC product portfolio.
 

Over-the-Counter Pain Medication Market, By Drug Type, 2014-2025 (USD Million)

• Acetaminophen
• Nonsteroidal anti-inflammatory drugs (NSAIDs)

Over-the-Counter Pain Medication Market, By Route of Administration, 2014-2025 (USD Million)

• Oral
• Topical

Over-the-Counter Pain Medication Market, By Dosage Form, 2014-2025 (USD Million)

• Tablet
• Capsules
• Cream
• Gels
• Sprays

Over-the-Counter Pain Medication Market, By Distribution Channel, 2014-2025 (USD Million)

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Argentina
  • Mexico
  • Brazil
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Company Profiles:

• Bayer AG,
• Bristol-Myers Squibb and Company
• Cardinal Health Inc.
• Dr. Reddy’s Laboratory
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.
• Merck & Co.
• Mylan N.V.
• Pfizer, Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceutical Industries Ltd.

What Information does this report contain?